Type 2 Inflammation Contributes to Skin Barrier Dysfunction in Atopic Dermatitis
skin colonization. Systemic anti‒type 2 inflammation therapies may improve dysfunctional skin barrier in AD.
skin colonization. Systemic anti‒type 2 inflammation therapies may improve dysfunctional skin barrier in AD.